NYSE:HUM Humana (HUM) Stock Price, News & Analysis $392.63 +6.23 (+1.61%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$387.71▼$400.5450-Day Range$345.31▼$401.8852-Week Range$298.61▼$530.54Volume875,957 shsAverage Volume1.74 million shsMarket Capitalization$47.31 billionP/E Ratio24.45Dividend Yield0.90%Price Target$402.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Humana alerts: Email Address Humana MarketRank™ Stock AnalysisAnalyst RatingHold2.41 Rating ScoreUpside/Downside2.5% Upside$402.60 Price TargetShort InterestHealthy2.14% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-0.75Upright™ Environmental ScoreNews Sentiment0.24Based on 39 Articles This WeekInsider TradingN/AProj. Earnings Growth21.27%From $16.27 to $19.73 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.74 out of 5 starsMedical Sector57th out of 936 stocksHospital & Medical Service Plans Industry6th out of 11 stocks 2.2 Analyst's Opinion Consensus RatingHumana has received a consensus rating of Hold. The company's average rating score is 2.41, and is based on 9 buy ratings, 13 hold ratings, and no sell ratings.Amount of Analyst CoverageHumana has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.14% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently decreased by 14.62%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldHumana has a dividend yield of 0.92%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 22.04%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 17.94% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHumana has received a 52.17% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Health insurance services for individuals", "Health insurance services for groups", and "Physical retail of pharmaceuticals at a pharmacy" products. See details.Environmental SustainabilityThe Environmental Impact score for Humana is -0.75. Previous Next 2.4 News and Social Media Coverage News SentimentHumana has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 39 news articles for Humana this week, compared to 19 articles on an average week.Search InterestOnly 19 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.MarketBeat Follows11 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 175% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.32% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Humana are expected to grow by 21.27% in the coming year, from $16.27 to $19.73 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 24.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.95.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 24.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 150.64.Price to Earnings Growth RatioHumana has a PEG Ratio of 2.23. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 2.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Humana's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIWe’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! About Humana Stock (NYSE:HUM)Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Read More HUM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HUM Stock News HeadlinesJuly 26 at 11:31 AM | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humana Inc. – HUMJuly 26 at 11:30 AM | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of HumanaJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 26 at 6:50 AM | americanbankingnews.comHumana's (HUM) "Neutral" Rating Reiterated at Cantor FitzgeraldJuly 26 at 5:45 AM | prnewswire.comClass Action Filed Against Humana Inc. (HUM) - August 2, 2024 Deadline to Join - Contact Levi & KorsinskyJuly 26 at 3:02 AM | americanbankingnews.comHumana (NYSE:HUM) PT Raised to $407.00 at TD CowenJuly 25 at 6:56 PM | markets.businessinsider.comHumana Expands Partnership With Google Cloud By Inking New Multi-year AgreementJuly 25 at 6:56 PM | msn.comHumana Clinics Are Moving Into Walmart’s Health Centers. It’s Just What the Doctor Ordered.July 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 25 at 12:36 PM | globenewswire.comLost Money on Humana Inc. (HUM)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyJuly 25 at 9:50 AM | prnewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of HumanaJuly 25 at 5:45 AM | prnewswire.comHumana Inc. Class Action: The Gross Law Firm Reminds Humana Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 2, 2024 - HUMJuly 24 at 4:35 PM | barrons.comHumana Clinics Are Moving Into Walmart's Health Centers. It's Just What the Doctor Ordered.July 24 at 2:04 PM | investing.comHumana shares target raised, rating sustained by TD CowenJuly 24 at 1:44 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humana Inc. - HUMJuly 24 at 1:06 PM | finance.yahoo.comHumana Healthy Horizons Commits to Increasing Healthcare Access for OklahomansJuly 24 at 1:06 PM | seekingalpha.comHumana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis IntactJuly 24 at 1:06 PM | forbes.comHumana To Open Clinics at Shuttered Former Walmart Health SitesSee More Headlines Receive HUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/24/2024Ex-Dividend for 7/26 Dividend6/28/2024Today7/26/2024Dividend Payable7/26/2024Next Earnings (Confirmed)7/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:HUM CUSIP44485910 CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,600Year Founded1961Price Target and Rating Average Stock Price Target$402.60 High Stock Price Target$579.00 Low Stock Price Target$310.00 Potential Upside/Downside+1.8%Consensus RatingHold Rating Score (0-4)2.41 Research Coverage22 Analysts Profitability EPS (Most Recent Fiscal Year)$16.06 Trailing P/E Ratio24.64 Forward P/E Ratio24.32 P/E Growth2.23Net Income$2.49 billion Net Margins1.82% Pretax Margin2.55% Return on Equity17.76% Return on Assets5.63% Debt Debt-to-Equity Ratio0.77 Current Ratio1.67 Quick Ratio1.67 Sales & Book Value Annual Sales$106.37 billion Price / Sales0.45 Cash Flow$35.11 per share Price / Cash Flow11.27 Book Value$132.55 per share Price / Book2.98Miscellaneous Outstanding Shares120,500,000Free Float120,115,000Market Cap$47.67 billion OptionableOptionable Beta0.51 Social Links Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Bruce Dale Broussard (Age 62)CEO & Director Comp: $1.94MMs. Susan Marie Diamond (Age 50)Chief Financial Officer Comp: $1.03MMr. Joseph C. Ventura (Age 47)Chief Legal Officer Comp: $840.36kMr. George Renaudin II (Age 55)President of Medicare & Medicaid Comp: $850.28kDr. Sanjay K. Shetty M.B.A. (Age 50)M.D., President of CenterWell Comp: $2.73MMr. James A. Rechtin M.B.A. (Age 53)President & COO Mr. John-Paul William Felter (Age 40)Senior VP, Chief Accounting Officer, Principal Accounting Officer & Controller Mr. Eric TagliereSenior VP & CTOMr. Samir M. Deshpande (Age 59)Chief Information Officer Mr. Timothy S. Huval (Age 58)Chief Administrative Officer Comp: $1.68MMore ExecutivesKey CompetitorsElevance HealthNYSE:ELVThe Cigna GroupNYSE:CICenteneNYSE:CNCMolina HealthcareNYSE:MOHUnitedHealth GroupNYSE:UNHView All CompetitorsInsiders & InstitutionsState of Michigan Retirement SystemSold 500 shares on 7/26/2024Ownership: 0.027%Bailard Inc.Sold 65 shares on 7/26/2024Ownership: 0.005%AustralianSuper Pty LtdBought 301 shares on 7/26/2024Ownership: 0.002%Checchi Capital Advisers LLCBought 144 shares on 7/26/2024Ownership: 0.001%Harbour Investments Inc.Bought 41 shares on 7/26/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions Should I Buy Humana Stock? HUM Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Humana Inc.: Humana's strong quarterly earnings results, beating consensus estimates, and showing a positive trend in revenue growth. Consistent dividend payments with a dividend yield of 1.01%, providing investors with a steady income stream. Positive analyst ratings with a majority of analysts giving a "buy" or "outperform" rating, indicating confidence in the company's performance. Low debt-to-equity ratio of 0.77, indicating a healthy financial position and lower risk for investors. Current stock price at an attractive level, potentially offering a good entry point for investors looking for value. Cons Investors should be bearish about investing in Humana Inc. for these reasons: Analysts lowering price targets on Humana stock, signaling potential concerns about future growth prospects. Neutral ratings from some analysts, suggesting uncertainty in the company's future performance. Market volatility and regulatory changes in the healthcare sector could impact Humana's business operations and financial results. Competition in the health insurance industry leading to pricing pressures and potential margin compression for Humana. Uncertainty surrounding healthcare policies and reforms that could affect Humana's profitability and market position. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, July 5, 2024. Please send any questions or comments about these Humana pros and cons to contact@marketbeat.com. HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $457.81 at the start of the year. Since then, HUM shares have decreased by 14.2% and is now trading at $392.63. View the best growth stocks for 2024 here. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) posted its quarterly earnings results on Wednesday, April, 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. The company's revenue was up 10.7% on a year-over-year basis. Read the conference call transcript. What is Bruce D. Broussard's approval rating as Humana's CEO? 1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees. Does Humana have any subsidiaries? Humana subsidiaries include Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others. Who are Humana's major shareholders? Humana's top institutional investors include Bank of New York Mellon Corp (0.70%), Allspring Global Investments Holdings LLC (0.52%), Sumitomo Mitsui Trust Holdings Inc. (0.27%) and Ceredex Value Advisors LLC (0.25%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Samir Deshpande, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA) and Boeing (BA). This page (NYSE:HUM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humana Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
